Los Angeles Cancer Network (LACN)

Los Angeles, California 91204

2 studies enrolling now · 3 studies all time

What they study most

Head and Neck Squamous Cell Carcinoma (HNSCC), Metastatic Castration-Resistant Prostate Cancer, Non-small Cell Lung Cancer

Studies at this site

• A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. — Recruiting now
• Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer — Recruiting now
• INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC — Running, not enrolling